Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Invitation: PROSTVAC(TM) Wrap up
June 10th, 2009
Following the presentation of data with PROSTVAC(TM) - a promising, late-stage vaccine candidate for the treatment of advanced prostate cancer, Bavarian Nordic will be hosting a Q&A session at the ASCO Annual Meeting. Time: Sunday, May 31st 2009 from 09 AM EDT to 10 AM EDT. Location: Rosen Centre Hotel, 9840 International Drive, Orlando, Florida 32819 At the Q&A session, Bavarian Nordic's PROSTVAC(TM) team and President & CEO, Anders Hedegaard will attend. The Q&A session follows the presentation of final Phase 2 data with PROSTVAC(TM) at the 2009 ASCO Annual Meeting. The presentation will take place on May 30,...
Source: Vaccine Weekly (2009-06-10)
|
